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ABSTRACT
Objectives: Supplementary assays are needed for determination of relationships between sperm biomarkers and fertility 
potential. Therefore, our research was designed to determine the extent of sperm DNA fragmentation (SDF) and establish 
a discriminating threshold of SDF for fertility potential. 
Material and methods: Semen characteristics were evaluated according to World Health Organization recommenda-
tions, and SDF was assessed by sperm chromatin dispersion test on ejaculated spermatozoa from infertile and healthy 
normozoospermic men. 
Results: A higher proportion of SDF was noted in infertile men (median 23.00%) than normozoospermic (median 14.00%). 
Significantly less subjects (17.03%) with low SDF level (≤ 15%) and more (35.17%) with high SDF level (> 30%) were found 
for the infertile group vs the normooospermic (57.90% and 5.26%, respectively). Infertile group had significantly lower odds 
ratio (OR) for having a low SDF level (OR: 0.1493) and higher OR for having a high SDF level (OR: 9.7627). Receiver operating 
characteristic analysis [area under curve (AUC) = 0.785] revealed that 20% SDF is predictive value for discriminating between 
infertile and normozoospermic subjects. SDF was negatively correlated with the sperm number, morphology, progressive 
motility and vitality but positively with the teratozoospermia index. 
Conclusions: Our study demonstrates: (1) a significant difference in the extent of SDF and in the risk for having damaged 
sperm DNA between infertile and normozoospermic men, (2) > 20% SDF has negative predictive value for fertility poten-
tial, (3) coexistence of abnormal standard sperm parameters with sperm chromatin damages. Therefore, SDF should be 
considered as a highly valuable indicator of male fertility potential.
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INTRODUCTION
Currently, infertility is a rapidly growing global problem 
for affected couples, public health and the economy be-
cause society is ageing. Infertility is estimated to globally af-
fect as many as 186 million people. Each year, approximately 
15–20% of couples suffer from the inability to have child. 
Based on recent data, we can estimate that a male factor 
(coexisting with a female factor) contributes to half of these 
issues, and approximately 30% of these cases are related to 
isolated male factor [1, 2]. Furthermore, male factors may be 
responsible for fertilization and embryo development fail-
ure, increases in the risk of idiopathic recurrent miscarriages 
and autosomal dominant diseases and neurobehavioural 
disorders in offspring, especially when the paternal age 
is taken into consideration [3, 4]. Thus, the diagnosis and 
treatment of male infertility cannot be overlooked in the 
era of assisted reproductive technology (ART), especially 
for in vitro fertilization, where natural selection is almost 
bypassed. Therefore, new diagnostic tests are needed for 
the evaluation of sperm biomarkers, which have predictive 
value for reproductive success. 
Sperm DNA fragmentation (SDF) is recognized as a com-
prehensive parameter that plays a key role in both natural 
and medically assisted procreation and can potentially con-
tribute to reduced reproductive success. Generally, two 
hypothesis have been proposed to explain the pathogenesis 
of SDF. Both the intrinsic factors (i.e. genetic factors, abortive 
apoptosis and defective sperm maturation) and extrinsic 
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factors (i.e. prolonged stasis during epididymal transit, vari-
cocele, drug use, smoking, alcohol consumption, obesity, 
environmental pollution, systematic infection and diseases) 
contributing to pathological generation of reactive oxygen 
species are recognized as major causative factors of sperm 
chromatin damage [5]. 
However, the impact of SDF on reproductive outcomes 
is unclear. It should be highlighted that in many cases this 
impact is dependent on sperm chromatin abnormality lev-
els. In this context, many authors try to find optimal thresh-
old of SDF for assessment of male fertility potential [6–9]. 
It is suggested that low SDF level (0–15% sperm cells with 
DNA fragmentation) corresponds to high fertility potential, 
moderate SDF level (16–30%) to moderate fertility poten-
tial while high SDF level (> 30%) to low fertility potential 
[7, 10–12]. The aim of this study was therefore to determine 
the extent of SDF and establish a discriminating threshold 
value of SDF for fertility potential.
MATERIAL AND METHODS
Subjects
The study was performed on semen samples obtained 
from subjects with abnormal standard semen parameters 
and proven infertility (n = 182, median age = 33 years) and 
healthy volunteers with normal standard semen character-
istics, i.e. normozoospermia (n = 114, median age = 27 years, 
potentially normal fertile status), at the Andrology Labora-
tory of Department of Histology and Developmental Biology 
(Pomeranian Medical University in Szczecin, Poland). The 
infertile group was created from couples who were treat-
ed/diagnosed for infertility. According to the World Health 
Organization (WHO) recommendations criteria of infertility, 
we considered cases that did not result in pregnancy after 
a minimum of 12 months of regular, unprotected sexual in-
tercourse [13]. In some cases (n = 46), male factors coexisted 
with female factors. For all participants, the exclusion criteria 
included: azoospermia; testicular injures, tumours or torsion 
incidences; co-existing systemic disease; and a history of 
mumps. The ethics committee of the Pomeranian Medical 
University, Szczecin, Poland approved the study protocol 
(ethical authorization number: KB-0012/88/11).
The semen samples were obtained by masturbation 
after 2–7 days of sexual abstinence. The standard semen 
characteristics were evaluated in accordance with WHO 
recommendations [13] (Tab. 1). Normozoospermia was con-
sidered according to the following criteria: total sperm cells 
count ≥ 39 mln, % of progressively motile sperm cells ≥ 32% 
and % of sperm cells with normal morphology ≥ 4%. 
In the group of infertile men, the following seminological 
categories were distinguished: asthenozoospermia (% of 
progressively motile sperm cells below the lower reference 
threshold, n = 2); oligozoospermia (total number of sperm 
cells below the lower reference threshold, n = 4); terato-
zoospermia (% of morphologically normal spermatozoa 
below the lower reference threshold, n = 77); asthenotera-
tozoospermia (% of both progressively motile and mor-
phologically normal sperm cells below the lower reference 
thresholds, n = 25); oligoteratozoospermia (total number of 
spermatozoa and % of morphologically normal spermato-
zoa below the lower reference thresholds, n = 36) and oli-
goasthenoteratozoospermia (total number of spermatozoa, 
% of both progressively motile and morphologically normal 
spermatozoa below the lower reference thresholds, n = 38).
Sperm chromatin dispersion (SCD) test
The SCD test was performed to evaluate SDF using a Ha-
losperm G2 kit (Halotech DNA, Madrid, Spain) following the 
manufacturer’s guidelines and methodology, including cal-
culation and interpretation of results which was described 
in our previous publications [14, 15].
Statistical analyses
The Statistica version 13.3 (StatSoft, Poland) and Med-
Calc version 15.2.2 (MedCalc Software, Belgium) software 
were used to perform statistical analyses. The quantitative 
variables are expressed as the mean ± standard deviation 
(SD) and median (interquartile, range), while categorical 
data are reported as percentages. Normal distribution were 
assessed using Shapiro–Wilk test, while Mann–Whitney 
U test was performed for comparison of two groups. A χ2 test 
was carried out to compare the categorical data. The inter-
dependences of the variables were examined by calculating 
the rank Spearman correlation coefficient (rs). The odds 
ratios (OR) for SDF levels to define the risk in predicting the 
level of SDF in group of infertile men with respect to group 
of normozoospermic donors were calculated. Statistical 
significance for all testes was defined as a p value of < 0.05.
RESULTS
The characteristics and comparison (age and standard 
semen parameters) of healthy normozoospermic volunteers 
and infertile men with abnormal semen parameters are 
presented in Table 1. The proportion of sperm cells with 
DNA fragmentation was significantly lower (p < 0.000001) 
in the healthy volunteers than the infertile men (median: 
14.00% vs 23.00%, respectively) (Fig. 1). 
Furthermore, the levels of sperm DNA fragmentation 
were designated based on the following criteria: low SDF 
level (0–15% sperm cells with fragmented DNA, high fertility 
potential), moderate SDF level (16–30%, moderate fertility 
potential) and high SDF level (> 30%, low fertility potential) 
[7, 10–12]. Healthy volunteers and infertile men differed 
significantly (p < 0.0001) at low levels (57.90% vs 17.03% 
subjects, respectively) and high levels (5.26% vs 35.17% 
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subjects, respectively) of SDF (Tab. 2). Additionally, the group 
of infertile men had significantly lower odds ratio (OR) for 
having a low SDF level (OR: 0.1493) and higher ORs for hav-
ing a high SDF level (OR: 9.7627) vs the men from group of 
healthy volunteers (Tab. 3). 
Based on receiver operating characteristic (ROC) analy-
sis, suggested optimal SDF threshold of 20% [area under 
curve (AUC) = 0.785, p < 0.001] was estimated to distin-
guish between infertile men with abnormal standard semen 
parameters and healthy normozoospermic men (Fig.  2). 
Furthermore, prevalence of men with > 20% SDF was sig-
nificantly higher in infertile men vs the men from group of 
healthy volunteers (63.74% vs 21.05%, respectively) (Tab. 4). 
Moreover, infertile men had higher ORs for having > 20% 
SDF (OR: 6.5909) vs healthy volunteers (Tab. 5). 
SDF positively correlated with male age (rs = 0.342), tera-
tozoospermia index (rs = 0.433) and peroxidase-positive cells 
(rs = 0.203) but negatively correlated with sperm concentra-
tion (rs = –0.289), total number of spermatozoa (rs = –0.243), 
sperm morphology (rs = –0.533), sperm progressive motil-
ity (rs = –0.554), and eosin-negative and HOS test-reactive 
sperm cells (rs = –0.492 and rs = –0.535, respectively) (Tab. 6). 
DISCUSSION
SDF measured by the Halosperm test reflects 
male fertility potential
The clinical significance and recommendations of sperm 
chromatin integrity are still not completely understood. 
However, the analysis of SDF is recommended and has 
a clinical predictive value in cases of varicocele, particu-
Table 1. Descriptive statistics of standard semen parameters of infertile men with abnormal standard semen characteristics (n = 182) and healthy 
normozoospermic volunteers (n = 114)
Parameters 
n
median (range)
mean ± SD
Total Infertile men Health volunteers
Age [y]
n = 296
31.00 (19.00–54.00)
31.19 ± 6.12
n = 182
33.00 (21.00–54.00)
33.45 ± 5.52
n = 114
27.00 (19.00–45.00)
27.57 ± 5.25
Semen volume [mL]
n = 296
3.50 (0.50–10.00)
3.70 ± 1.67
n = 182
3.00 (0.50–9.00)
3.41 ± 1.59
n = 114
4.00 (1.00–10.00)
4.16 ± 1.70
Sperm concentration [× 106/mL]
n = 296
20.76 (0.40–283.00)
28.60 ± 29.94
n = 182
14.44 (0.40–147.50)
23.80 ± 25.96
n = 114
29.90 (8.25–283.00)
36.28 ± 34.12
Total number of spermatozoa [× 
106]
n = 296
70.11 (0.89–566.00)
98.87 ± 94.82
n = 182
47.00 (0.89–489.00)
78.87 ± 18.00
n = 114
105.60 (39.00–566.00)
139.23 ± 104.09
Morphologically normal 
spermatozoa [%]
n = 296
2.00 (0.00–15.00)
3.24 ± 3.05
n = 182
1.00 (0.00–7.00)
1.24 ± 1.31
n = 114
6.00 (4.00–15.00)
6.42 ± 2.22
TZI
n = 296
1.50 (1.20–2.30)
1.55 ± 0.18
n = 182
1.61 (1.20–2.30)
1.62 ± 0.19
n = 114
1.43 (1.23–1.67)
1.62 ± 0.19
Progressive motility [%]
n = 296
53.00 (0.00–86.00)
49.28 ± 21.34
n = 182
41.00 (0.00–81.00)
39.23 ± 19.88
n = 114
65.00 (32.00–86.00)
65.30 ± 11.59
Non-progressive motility [%]
n = 296
7.00 (0.00–26.00)
7.50 ± 4.53
n = 182
6.00 (0.00–26.00)
6.57 ± 4.50
n = 114
8.00 (0.00–23.00)
9.05 ± 4.16
Eosin-negative spermatozoa 
— live cells [%]
n = 296
78.00 (0.00–95.00)
73.78 ± 15.60
n = 182
74.00 (0.00–91.00)
81.50 ± 8.44
n = 114
83.00 (48.00–95.00)
68.92 ± 17.06
HOS test-positive spermatozoa 
— live cells [%]
n = 271
77.00 (0.00–94.00)
73.14 ± 15.90
n = 157
72.00 (0.00–88.00)
81.38 ± 8.24
n = 114
83.00 (50.00–94.00)
67.15 ± 17.40
Peroxidase-positive cells [mln/mL]
n = 296
0.10 (0.00–10.00)
0.37 ± 0.86
n = 182
0.25 (0.00–10.00)
1.04 ± 0.00
n = 114
0.00 (0.00–1.50)
0.24 ± 0.00
n — number of subjects; SD — standard deviation; HOS test — hypo-osmotic swelling test; TZI — teratozoospermia index
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larly for varicocelectomy, unexplained infertility, recurrent 
pregnancy loss, unsuccessful ART procedures, unhealthy 
lifestyle and advanced male age. Knowledge about the scale 
Figure 1. Comparison of sperm DNA fragmentation (SDF) in healthy 
volunteers (n = 114) and infertile men (n = 182); * — significant 
difference at p < 0.000001; Q1–Q3 — lower-upper quartile; 
Mann–Whitney U test; Insert — results of sperm chromatin dispersion 
test: sperm cells without fragmented nuclear DNA (a), with fragmented 
nuclear DNA (b, c) and degraded DNA (d); Scale bar = 20 µm
Figure 2. Receiver operating characteristic (ROC) curve of sperm  
DNA fragmentation for predicting male fertility potential; AUC  
— area under the curve; p ≤ 0.05 — statistical significance between 
obtained AUC vs AUC = 0.5; 95% CI — 95% confidence interval;  
SE — standard error; The following level of AUC were presumed:  
> 0.7–0.8 — satisfactory predictive value
Table 2. Prevalence of sperm chromatin fragmentation (SDF) levels 
in group of infertile man with abnormal standard semen parameters 
(n = 182) and group of healthy volunteers with normal standard 
semen parameters (n = 114)
Group
SDF [%]
0–15% 
n (%)
16–30% 
n (%)
 > 30% 
n (%)
Infertile men 31 (17.03)* 87 (47.80) 64 (35.17)*
Healthy volunteers 66 (57.90) 42 (36.84) 6 (5.26)
n — number of subjects; * — significant difference between compared 
groups at p < 0.0001; Chi2 test
Table 3. Odds ratio (OR) for sperm chromatin fragmentation (SDF) 
levels in the group of infertile men with abnormal standard semen 
characteristics (n = 182) and group of healthy normozoospermic 
volunteers (n = 114)
Infertile men Healthy volunteers OR (95% CI)
SDF  
0–15% 31 (17.03) 66 (57.90)
0.1493*  
(0.0873–0.2553) 
SDF  
16–30% 87 (47.80) 42 (36.84)
1.5699  
(0.9724–2.5345)
SDF  
> 30% 64 (35.17) 6 (5.26)
9.7627*  
(4.0632–23.4569)
n — number of subjects; * — statistical significance at p < 0.0001;  
95% CI — 95% confidential interval
Table 4. Prevalence of sperm chromatin fragmentation (SDF) levels 
in group of infertile man with abnormal standard semen parameters 
(n = 182) and group of healthy volunteers with normal standard 
semen parameters (n = 114)
Group
SDF [%]
0–20% 
n (%)
> 20% 
n (%)
Infertile men 66 (36.26)* 116 (63.74)*
Healthy volunteers 90 (78.95) 24 (21.05)
n — number of subjects; * — significant difference between compared 
groups at p < 0.0001; Chi2 test
of DNA abnormalities play a key role in the development of 
an optimal treatment algorithm for male infertility [5, 16, 17]. 
Generally, sperm cells with > 30% immature chromatin 
is a cut-off point for a high risk of infertility [6–8, 10–12, 18]. 
Bungum et al. [18] showed that in the range of 0–20% sperm 
DNA fragmentation, the chance of a spontaneous preg-
nancy was constant, while DNA fragmentation index (DFI) 
levels > 30–40% resulted in reduced chances close to zero. 
However, these 2 categories can reasonably be extended 
to 3, as proposed by Leach et al. [7], Abdelbaki et al. [10] 
and Al Omrani et al. [12]. In this division, a threshold of 
0–15% is considered a high fertility potential, while 16–30% 
and > 30% are considered moderate and low fertility poten-
tials, respectively. Likewise, in our present group of infertile 
patients, 35.17% of the subjects exhibited a high level of SDF 
(> 30%) compared to 5.26% of the subjects in the healthy 
normozoospermic group. An inverse relationship was found 
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for the low level of sperm DNA fragmentation (0–15%), only 
17.03% of men in the infertile group and 57.90% of men in 
the control group had low levels. Furthermore, the ORs for 
having a low SDF level or high SDF level significantly dis-
criminated infertile men from healthy volunteers. Infertile 
men were morethan six times as likely to have not a low 
SDF level (OR: 0.1493) and had more than nine times the risk 
for having a high SDF level (OR: 9.7627). The prevalence of 
sperm chromatin damage revealed in our study was consist-
ent with the Mann-Whitney U test results. In this study, the 
median value of SDF was significantly higher in the infertile 
group than the control group (median 23.00% vs 14.00%). 
On the other hand, ROC analysis used to examine the 
frequency distribution of the SDF results, provided new data. 
Suggested optimal SDF threshold to distinguish between 
healthy normozoospermic men and infertile men was 20%. 
The prevalence of men with > 20% SDF was significantly 
higher and OR for having > 20% SDF was over six-times 
higher in infertile men vs healthy volunteers. Therefore, 
we can conclude that >20% SDF has negative predictive 
value for male fertility potential. It should be emphasized 
that suggested threshold value of 20% SDF differs from the 
value given by the Halosperm G2 kit manufacturer (30% 
SDF). Therefore, our results may suggest that men with 
20–30% SDF can be incorrectly classified as a men with 
normal fertility potential. 
Presented above results are in agreement with data 
from other authors. Marchlewska et al. [19] reported that 
men from infertile couples had 28.00% spermatozoa with 
SDF. Majzoub et al. [20] revealed significant differences in 
SDF between infertile and fertile men (mean: 27.60 ± 1.02% 
vs 15.68 ± 0.92%). In turn, Wiweko and Utami [9] demonstrat-
ed not only significant differences in SDF between infertile 
and fertile men (median 29.9% vs 19.9%) but also the ability 
of SDF to diagnose male infertility by an ROC curve. In addi-
tion, Tandara et al [21] showed the useful predictive value 
of SDF for fertilization. Moreover, Zheng et al. [22] observed 
that patients in a pregnant group had significantly lower 
levels of SDF than patients without reproductive success 
(mean: 24.41 ± 7.24% vs 29.95 ± 11.20). Furthermore, pa-
tients who had sperm DNA damage ≤ 10% had a higher 
good embryo rate, blastocyst formation rate, implantation 
rate and clinical pregnancy rate than those who had ≥ 21% 
sperm DNA damage. In the group with better DNA integrity, 
a lower abortion rate was observed. A compatible signifi-
cance of the Halosperm test during ICSI was presented by 
Sivanarayana et al. [23] who divided patients into groups 
with ≥ 30% or < 30% SDF. The authors discovered connec-
tions between SDF and standard semen parameters (men 
from group ≥ 30% SDF had significantly lower semen qual-
ity) and clinical outcomes. A higher level of SDF is associated 
with a reduced number of 8-cell embryos on the 3rd day after 
fertilization and the number of blastocysts formed on the 
5th day in addition to lower clinical pregnancy and delivery 
rates and a higher miscarriage rate. Furthermore, Khadem 
et al. [24] discovered that men from couples with recurrent, 
spontaneous abortion had significantly higher levels of SDF 
than those of the control group (mean 43.3% vs 16.7%). 
Additionally, Absalan et al. [25] reported similar results; i.e., 
men from couples with unexplained, recurrent abortion 
Table 5. Odds ratio (OR) for sperm chromatin fragmentation (SDF) levels in the group of infertile men with abnormal standard semen characteristics 
(n = 182) and group of healthy normozoospermic volunteers (n = 114)
Infertile men Healthy volunteers OR (95% CI)
SDF > 20% 116 (63.74) 24 (21.05) 6.5909* (3.8321–11.3359)
n — number of subjects; * — statistical significance at p < 0.0001; 95% CI — 95% confidential interval
Table 6. Rank Spearman correlations (rs) between human sperm 
chromatin fragmentation (SDF), male age and standard semen 
parameters (n = 296)
Parameters SDF
Age [y] 0.342p < 0.000001 
Semen volume [mL] –0.009p = 0.872
Sperm concentration [× 106/mL] –0.289p < 0.000001
Total number of spermatozoa [× 106] –0.243p = 0.000023
Morphologically normal spermatozoa [%] –0.533p < 0.000001
TZI 0.433p < 0.000001
Progressive motility [%] –0.554p < 0.000001
Non-progressive motility [%] –0.137p = 0.019
Eosin-negative spermatozoa — live cells [%] –0.492p < 0.000001
HOS test-positive spermatozoa — live cells [%] –0.535p < 0.000001
Peroxidase-positive cells [mln/mL] 0.203p = 0.0004
The interpretation of rs value: < 0.2 lack of linear dependence, 0.2–0.4 — weak 
dependence, 0.4–0.7 — moderate dependence, 0.7–0.9 — strong 
dependence, > 0.9 — very strong dependence; SDF — sperm chromatin 
fragmentation; n — number of subjects, statistical significance at p < 0.05; 
HOS test — hypo-osmotic swelling test, TZI — teratozoospermia index
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had significantly higher proportions of sperm cells without 
halos (degenerated DNA) than healthy volunteers (mean: 
23.26 ± 1.10% vs 11.60 ± 0.50%) and lower proportions of 
spermatozoa with large halos (without DNA fragmentation) 
(41.40 ± 1.43 vs 65.93 ± 2.35%). In contrast, Coughlan et al. [26] 
observed the ambiguous influence of SDF. Men from cou-
ples with recurrent implantation failure had 20.1 ± 2.9% 
sperm cells with DNA damage, and subjects from couples 
with recurrent miscarriage had 15.1 ± 3.6% vs men with 
proven fertility (16.4 ± 3.7%). Thus, based on the described 
data, SDF measured by the Halo test can reasonably be as-
sumed to reflect male fertility potential.
Relationships between human standard semen 
characteristics and sperm chromatin dispersion
Moreover, our study exhibited significant correlations 
between SDF and age, sperm concentration, total num-
ber of spermatozoa, sperm cell morphology, teratozoo-
spermia index (TZI), sperm cell progressive motility, vitality 
and concentration of peroxidase-positive cells in ejaculate. 
Other authors also indicate similar correlations. Significant 
associations were found between sperm cells with large 
halos and the sperm concentration, motility, morphology 
and vitality (r = 0.26, r = 0.37, r = 0.43 and r = 0.49, respec-
tively) but not the fertilization rate (r = 0.01) [21]. Addition-
ally, Khadem et al. [24] showed a significant correlation 
between SDF and sperm cell motility and morphology 
(r = –0.613 and r = –0.764, respectively). Moreover, Majoub 
et al. [20] presented relationships between SDF and normal 
sperm morphology in groups of infertile and fertile men 
(rs = –0.351 and rs = –0.257, respectively), especially with 
head defects (rs = 0.438 and rs = 0.366, respectively). Similarly, 
Fortunato et al. [27] found a correlation between SDF and 
the percentage of normal sperm cells formed and multiple 
morphological abnormalities (r = –0.283 and r = 0.233, re-
spectively). Another study revealed correlations between 
SDF and sperm motility and morphology (r = –0.282 and 
r = –0.340, respectively) and between SDF and the percent-
age of normal X or Y sperm chromosome (r = –0.559) [28]. 
Furthermore, Zheng et al. [22] showed negative correlations 
between SDF results and the good embryo rate (rs = –0.330), 
blastocyst formation rate (rs = –0.320), embryo implanta-
tion (rs = –0.208), and clinical pregnancy (rs = –0.221). The 
described findings suggest a relationship exists between 
standard semen and SDF that affects male fertility potential. 
Therefore, efforts to improve sperm quality are justified un-
der natural conditions and medically assisted reproduction.
Limitations and strengths of the study 
This study was not without limitations. As a control 
group we considered a healthy normozoospermic volun-
teers who declared no problems with conception, chronic 
diseases, trauma of testis or any other factors which could 
affect male fertility. Therefore, we presume that this group 
presented normal fertility potential. On the other hand, we 
cannot be sure that all of them were fertile. Another known 
limitation is associated with SCD method which was perform 
to evaluation of sperm DNA integrity. SCD is not a direct 
method of DNA breaks assessment in contrast to comet as-
say, TUNEL or SCSA [6, 29–31], but yet this method has some 
significant diagnostic and clinical advantages. Halosperm 
G2 is ready to use kit which minimizes the risk of mistakes 
and positive or negative false results. Also methodology is 
easy to perform and not required more than basic laboratory 
skills. Moreover, SCD seems to be economically justified be-
cause for visualization of SDF uses simple light microscope in 
opposition to TUNEL or SCSA methods where application of 
expensive flow cytometer is required [6, 14, 15]. As forother 
strengths of our study, we wanted to highlighted some 
facts. Despite that our control group does not contain only 
men with proven fertile status, our results of SDF assess-
ment were in agreement with other researchers, who have 
shown that clinically significant threshold to discriminated 
men with proven fertility from infertile men is approximately 
15–20% [18, 19, 32, 33]. Moreover, all participants both nor-
mozoospermic volunteers and diagnosed infertile patients 
came to the same laboratory and the analysis of their semen 
was carried out in exactly the same way. Furthermore, semen 
assessment took only one year. We believe that such a short 
period of time should eliminate the impact of external fac-
tors like environmental pollution, unhealthily diet or life 
style trends which may change over the years. It seems to 
be important, because many authors underline alarming 
trend in decline of semen quality visible every few years [34].
CONCLUSIONS 
Our paper highlighted that: 1) abnormal standard sperm 
parameters coexist with sperm chromatin abnormalities, 
2) the risk for having a high level of sperm DNA damage 
increases when conventional sperm characteristics are re-
duced, 3) > 20% SDF (our calculated cut-off point) has nega-
tive predictive value for male fertility potential, 4) the men 
with 20–30% SDF should be considered as a men with a risk 
of reduced fertility potential. Therefore, routinely incorporat-
ing sperm chromatin dispersion testing into the evaluation 
of male fertility potential is important and will allow an op-
portunity for correct therapeutic management to potentially 
restore the natural fertility of a patient, enroll them in ART 
procedures, or exclude them from ART procedures due to 
the high level of DNA damage. 
It should be underlined that in case of high SDF levels 
some authors suggest possible treatment strategies to re-
duce SDF (e.g. lifestyle modifications, treatment of varicocele 
and urogenital infections, antioxidants therapy) and in-
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crease the chance to achieve pregnancy by natural concep-
tion or ART [5, 17, 35]. The effects of the treatment should be 
evaluated after 3 months (duration of spermatogenesis and 
two weeks of sperm cells transit through the epididymis). On 
the other hand, long time of sexual abstinence is negatively 
associated with sperm integrity and it is worth to evaluate 
SDF levels after short sexual abstinence time, which can be 
especially important in case of ART. Therefore, the algorithm 
indicates the need to repeat SDF analysis and based on the 
new diagnostic data preferential and individual therapeutic 
strategy should be made [5, 17, 35–37].
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